Literature DB >> 1565182

A disease-specific questionnaire for assessing quality of life in patients on hemodialysis.

A Laupacis1, N Muirhead, P Keown, C Wong.   

Abstract

A disease-specific questionnaire was developed for patients receiving chronic hemodialysis by interviewing patients to determine which aspects of their quality of life were adversely affected by their disease. The final questionnaire contained 26 questions in five dimensions (physical symptoms, fatigue, depression, relationships with others, frustration). The questionnaire demonstrated construct validity when compared with the Sickness Impact Profile, time trade-off technique and an exercise stress test. It was reproducible in stable, placebo-treated patients (correlation coefficient 0.85-0.98 for the 5 dimensions). It was more responsive than other measures in detecting an improvement with erythropoietin therapy in a randomized, placebo-controlled trial. This questionnaire should be useful for the assessment of the effect of various interventions upon the quality of life of hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1565182     DOI: 10.1159/000186769

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  32 in total

1.  Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire.

Authors:  P Carmichael; J Popoola; I John; P E Stevens; A R Carmichael
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

2.  The SF36 as an outcome measure of services for end stage renal failure.

Authors:  J P Wight; L Edwards; J Brazier; S Walters; J N Payne; C B Brown
Journal:  Qual Health Care       Date:  1998-12

3.  The validation and psychometric properties of the Dutch version of the Swallowing Quality-of-Life Questionnaire (DSWAL-QOL).

Authors:  Jan Vanderwegen; Gwen Van Nuffelen; Marc De Bodt
Journal:  Dysphagia       Date:  2012-05-10       Impact factor: 3.438

4.  On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis.

Authors:  M M Murawski; P A Miederhoff
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

Review 5.  Low-dosage epoetin in maintenance haemodialysis: costs and quality-of-life improvement.

Authors:  D C Harris
Journal:  Pharmacoeconomics       Date:  1994-01       Impact factor: 4.981

Review 6.  Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.

Authors:  R Whittington; L B Barradell; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

Review 7.  A review of quality of life in chronic renal failure.

Authors:  D S Parsons; D C Harris
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

8.  Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol.

Authors:  Giovanni F M Strippoli
Journal:  Trials       Date:  2010-06-09       Impact factor: 2.279

9.  Health-related quality of life in endstage renal failure.

Authors:  C M Gudex
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

Review 10.  Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors.

Authors:  Manisha Jhamb; Steven D Weisbord; Jennifer L Steel; Mark Unruh
Journal:  Am J Kidney Dis       Date:  2008-06-24       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.